Download Files:
MAFP
SKU
HY-103334-1 mg
Category Reference compound
Tags Metabolic Disease; Neurological Disease; Cardiovascular Disease, Metabolic Enzyme/Protease, Phospholipase
$90 – $1,350
Products Details
Product Description
– MAFP (Methyl Arachidonyl Fluorophosphonate) is an selective, active-site directed and irreversible inhibitor of cPLA2 and iPLA2. MAFP is also a potent irreversible inhibitor of anandamide amidase.
Web ID
– HY-103334
Storage Temperature
– -80°C, protect from light
Shipping
– Dry Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– C21H36FO2P
References
– [1]Lio YC, et al. Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta. 1996 Jul 12;1302(1):55-60.|[2]Deutsch DG, et al. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol. 1997 Feb 7;53(3):255-60.
CAS Number
– 188404-10-6
Molecular Weight
– 370.48
Compound Purity
– 98.0
SMILES
– CCCCC/C=CC/C=CC/C=CC/C=CCCCCP(OC)(F)=O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease; Neurological Disease; Cardiovascular Disease
Solubility
– DMSO : ≥ 100 mg/mL
Target
– Phospholipase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.